BioInnovation Institute

Berlin cityscape
#BioInnovation Institute #Biotech #Cardiometabolic diseases #Drug discovery #Europe

German hubs selected for BII cardiometabolic research initiative

BioInnovation Institute (BII) has selected Munich and Berlin as the locations for its German activities under the CardioMetabolic Bridge (CMB) initiative.   The expansion marks another important milestone in BII’s ambition to build a connected European innovation ecosystem dedicated to accelerating the development of new treatments for cardiometabolic… Read More

#News

#BioInnovation Institute #Drug discovery #European innovation #Novo Nordisk Foundation #Start-ups

BII scales up and supports record-high number of new startups

Seventeen new companies will now benefit from BioInnovation Institute (BII)’s innovation platform, which helps companies attract capital and bring promising technologies to market. The innovation house is providing a total of around €9.5 million. Following the announcement of a new €736 million from the Novo Nordisk Foundation to the BII,… Read More

#News

#BioInnovation Institute #Drug discovery #Funding #Investment

BII allocates eight million euros to three drug discovery companies

Six promising companies will receive additional funding of €1.3 ($1.5) million each from BioInnovation Institute (BII) to help them bring their technologies and products closer to market.  The six companies – PanTarg, 3Sonic, Inia Biosciences, Yngvi Bio, Proxi Biotech and Sagava – have all previously received €0.5… Read More

#Business & Investment #News

Victoria House, London
#BioInnovation Institute #Biotech hubs #Cardiometabolic diseases #UK

BII boosts cardiometabolic innovation with new UK base

BioInnovation Institute (BII), a leading institute for life science and deep tech start-ups, has chosen its first research space outside of its headquarters in Copenhagen – Victoria House in London.  The London hub, which was developed by Pioneer Group and Oxford Properties, will serve as the flagship… Read More

#News

European map
#BioInnovation Institute #Denmark #Europe #Life sciences #Novo Nordisk Foundation

Novo Nordisk Foundation pledges €736m for scientific innovation 

The Novo Nordisk Foundation has granted DKK 5.5 billion (€736 million) to the BioInnovation Institute (BII) to support life sciences and scientific innovation in Denmark and Europe.  The funding will enable BII to expand its activities into new strategic areas and geographies, supporting even more entrepreneurs and start-up-companies.  … Read More

#Business & Investment #News

Gold compound
#Alzheimer's #BioInnovation Institute #Biotech hubs #Cognition Therapeutics #India #Interview #Market reporting #Neurodegenerative disorders #Neuroscience #Pregnancy #Start-ups #Women's health

Podcast: Where are scientists making waves in drug discovery?

This is the latest episode of the free DDW narrated podcast, titled “Where are scientists making waves in drug discovery?”, which covers three articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: “How pharma is targeting advances in Alzheimer’s treatments”, “The start-up disrupting… Read More

#News

#BioInnovation Institute #Biologics / Biotechnology #Biotech hubs #Drug discovery #Funding #Investment #Life sciences #Market reporting #Start-ups #United States

New podcast: Global epicentres of drug discovery innovation

This is the latest episode of the free DDW narrated podcast, titled “Where are the global epicentres of drug discovery innovation?”, which covers two articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: Where are the hottest drug discovery hubs in the… Read More

#News

RNA
#Aarhus University #BioInnovation Institute #mRNA #RNA #Small RNA #Start-ups

smartRNA project joins BII Bio Studio programme

A project focused on developing a small RNA-based platform technology for treating monogenic diseases, smartRNA, has joined the BioInnovation Institute’s (BII) Bio Studio programme. The approach to achieve this involves delivering an engineered small artificial (smart)RNA into the cell, where it assembles with endogenous protein co-factors… Read More

#News #Start-up Zone

#Amplify Therapeutics #BioInnovation Institute #Funding #Fuse Vectors #Metsystem #Parkinson's

Three companies join the BioInnovation Institute programme  

BioInnovation Institute (BII), life science incubator, has announced the addition of six companies who will receive additional financial support through its Venture House programme, created to further support former Venture Lab companies through their next phase of growth. Three of these are key to the advancement of gene therapies,… Read More

#News

Seed fund
#BioInnovation Institute #Financing #Mental health #Plant-based #Start-ups

$3M funding for plant-inspired halogenated small molecule drugs

Biomia, the first company spun out from BioInnovation Institute’s Bio Studio programme, has secured $3 million in pre-seed financing from an international syndicate of investors. Biomia says it plans to use the investment to accelerate its development of plant-inspired natural and new-to-nature halogenated small molecule drug… Read More

#Business & Investment #News #Start-up Zone

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Three therapeutics start-ups join acceleration programme

The BioInnovation Institute (BII) has welcomed three new drug discovery start-ups into its Venture Lab acceleration programme as part of its latest cohort of eight companies. The 12-month Venture Lab programme is designed to support start-up companies with business acceleration, scientific and team development, and provides… Read More

#News #Start-up Zone

Lightbulb, ideas, innovation
#AI #Animal models #Animal testing #BioInnovation Institute #Data science #Drug discovery #Drug research #Microbiome #Regulatory

New podcast: Innovate to reinvent the future of drug discovery

This is the latest episode of the free DDW narrated podcast, “Innovating now to reinvent the future of drug discovery”. It covers three articles written for Volume 23, Issue 2 – Spring 2022 of DDW. They are called “Predictive biomarkers in the… Read More

#News

Seed fund
#BioInnovation Institute #Denmark #Immunotherapy #InProTher #Investment #Oncology #Seed funding #Start-ups

Danish immunotherapy start-up raises €6M seed funding

Danish start-up InProTher has raised €6 million seed funding from private investors, with participation from the European Innovation Council (EIC) Fund. The financing will enable InProTher to advance its lead drug candidate, IPT001, a first-in-class immunotherapy against solid tumours, into clinical development. Incubated at… Read More

#Business & Investment #News #Start-up Zone

#BioInnovation Institute #Drug discovery #Funding #Investment #Start-ups

Global start-ups: where is the innovation?

Listen to this article on the DDW Podcast: DDW takes a look at some key global activity taking place around the world for drug discovery and life sciences start-ups. UK Budget a ‘shot in the arm’ for oncology start-ups Before the UK announced… Read More

#Exclusive Content #Start-up Zone

Woman talking to a doctor
#BioInnovation Institute #Collaboration #Ferring Pharmaceuticals #Partnership #Start-ups #Women's health

Partners accelerate innovation in underserved women’s health

BioInnovation Institute Foundation (BII) and Ferring Pharmaceuticals have expanded their collaboration with the objective to accelerate world-class life science innovation within women’s health. New activities will include supporting BII to source and potentially fund and incubate early-stage start-ups and projects within the field of reproductive medicine. Read More

#News